Skip to main content
Clinical Trials/NCT03840499
NCT03840499UnknownNot Applicable

The Role of Willingness of Participation in Cardiology Trials on the Survival of Patients

Semmelweis University Heart and Vascular Center1 site in 1 country400 target enrollmentStarted: October 1, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
400
Locations
1
Primary Endpoint
All-cause mortality

Study Overview

Brief Summary

It has been shown retrospectively that participation and even the willingness improves the survival of patients after myocardial infarction or heart failure. We aimed to prospectively analyse the role of participation in cardiology trials on the survival of patients in a high volumen tertiary center.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Hospitalisation due to acute myocardial infarction, and or heart failure
  • Singed informed consent

Exclusion Criteria

  • Previous participation in any clinical study
  • Haemodinamically instable, shock, intubation
  • Pregnancy, breast feeding

Arms & Interventions

Willing to participate in clinical study

Intervention: Optimal medical therapy (Drug)

Not-willing to participate in clinical study

Intervention: Optimal medical therapy (Drug)

Outcomes

Primary Outcomes

All-cause mortality

Time Frame: 2-years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Semmelweis University Heart and Vascular Center
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials